Eterna Therapeutics Inc Capital Reinvestment Ratio
Eterna Therapeutics Inc capital reinvestment ratio. Eterna Therapeutics Inc (ERNA) has a Capital Reinvestment Ratio of 0.05x as of March 2019, meaning it reinvests 0% of its operating cash flow ($780.00K) in capital expenditures ($41.00K). Check Eterna Therapeutics Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Eterna Therapeutics Inc (2009–2019)
Capital reinvestment ratio of Eterna Therapeutics Inc from 2009 to 2019. This chart tracks Eterna Therapeutics Inc's Capital Reinvestment Ratio across 9 annual periods. Also explore Eterna Therapeutics Inc net asset momentum to track the company's year-over-year net asset growth rate.
Eterna Therapeutics Inc Capital Reinvestment Ratio by Year (2009–2019)
Eterna Therapeutics Inc capital reinvestment ratio by year from 2009 to 2019. For the full cash flow conversion analysis, see ERNA operating cash flow.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2019 | 0.40x | $2.74 Million | $1.09 Million | ▼ -66.2% |
| 2018 | 1.18x | $1.36 Million | $1.61 Million | ▼ -55.3% |
| 2017 | 2.64x | $549.00K | $1.45 Million | ▼ -92.8% |
| 2016 | 36.52x | $23.00K | $840.00K | ▲ +6233.0% |
| 2013 | 0.58x | $1.49 Million | $861.00K | ▲ +1.4% |
| 2012 | 0.57x | $2.16 Million | $1.23 Million | ▼ -79.5% |
| 2011 | 2.78x | $574.00K | $1.59 Million | ▲ +494.2% |
| 2010 | 0.47x | $2.83 Million | $1.32 Million | ▼ -38.8% |
| 2009 | 0.76x | $2.50 Million | $1.91 Million | — |